European Companies Search Engine

Quick Search Power Search
Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Biosyntia ApS, Copenhagen, Denmark

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Biosyntia ApS

Register

Cvrcom
CVR 34892970

Address

Fruebjergvej 3, 2100 København, Denmark

Corporate purpose

The company's purpose is to conduct research, development and production of bio-based chemicals.

Additional info

71.12
Engineering activities and related technical consultancy

Financials

Earnings Employees

Earnings

For this company, Earnings numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Legal Representatives

Marketing & Tech

Network

Loading network

JOBS AT NORTH DATA

  • Director, Engineering
  • Modern Java Developer

Publications

19 Jun 2023
Annual report for the year ending 31/12/2022
5 Jun 2023
Persons
4 Oct 2022
Capital: 801,859 DKK · Company statute
30 Sept 2022
Beneficial Owner (1)
30 Sept 2022
Beneficial Owner (1)
30 Sept 2022
Beneficial Owner (1)
30 Sept 2022
Beneficial Owner (1)
30 Sept 2022
Beneficial Owner (1)
30 Sept 2022
Beneficial Owner (1)
30 Sept 2022
Beneficial Owner (1)
30 Sept 2022
Member of the Executive Board: Sara Sande
30 Sept 2022
Beneficial Owner (1)
24 Aug 2022
Persons · Capital: 635,656 DKK · Company statute
14 Jul 2022
Patent: Microbial Cell Factories Producing Vitamin B Compounds
20 Jun 2022
Member of the Executive Board: Morten O. A. Sommer
20 Jun 2022
Member of the Executive Board: Michael Nettersheim
28 Apr 2022
Annual report for the year ending 31/12/2021
15 Nov 2021
Company statute
6 Oct 2021
Patent: Cell Factory Having Improved Iron-Sulfur Cluster Delivery
30 Aug 2021
Company statute
15 Jun 2021
Annual report for the year ending 31/12/2020
14 Jun 2021
Patent: Methods for Producing Biotin in Genetically Modified Microorganisms
14 May 2020
Annual report for the year ending 31/12/2019
22 Apr 2020
Patent: A Genetically Modified Bacterial Cell Factory for Thiamine Production
15 Jan 2020
Patent: Cell Factories for Improved Production of Compounds and Proteins Dependent on Iron Sulfur Clusters
6 Dec 2019
Persons
6 Dec 2019
Member of the Executive Board: Thomas Grotkjær
6 Dec 2019
Member of the Executive Board: Søren Møller
24 Jul 2019
Patent: Regulatable Gene Expression
29 May 2019
Annual report for the year ending 31/12/2018
16 Jan 2019
Patent: Cell Factories for Improved Production of Compounds and Proteins Dependent on Iron Sulfur Clusters
17 Dec 2018
Beneficial Owner (1)
17 Dec 2018
Beneficial Owner (1)
17 Dec 2018
Capital: 287,146 DKK · Company statute
13 Dec 2018
Company statute
1 Jun 2018 in Sat
State Aid (4,825,937 DKK): Innobooster
31 May 2018
Annual report for the year ending 31/12/2017
24 Apr 2018
Persons · Capital: 217,888 DKK · Company statute
24 Apr 2018
Member of the Executive Board: Joško Bobanović
1 Jan 2018 in Fts
EU funding (€276,178): 764591 - Syncrop - Synthetic Circuits for Robust Orthogonal Production
28 Aug 2017 via Biofaction KG
EU funding (€290,082): Synthetic Circuits for Robust Orthogonal Production
31 Jul 2017
Director: Morten O. A. Sommer
15 Jul 2017
Persons
15 Jul 2017
Persons
17 May 2017
Annual report for the year ending 31/12/2016
1 Jan 2017 in Fts
EU funding (€542,891): 720776 - Rafts4Biotech - Synthetic Bacterial Lipid Rafts to Optimize Industrial Bioprocesses
22 Nov 2016 in Hor
EU funding (€555,250): Synthetic bacterial lipid rafts to optimize industrial bioprocesses
28 Jul 2016
Address
15 Jul 2016
Capital: 148,630 DKK · Company statute
4 Jul 2016
Auditor: RSM P/S Statsautoriserede Revisorer
1 Jun 2016
Annual report for the year ending 31/12/2015
1 Mar 2016 in Fts
EU funding (€247,383): 686070 - DD-Decaf - Bioinformatics Services for Data-Driven Design of Cell Factories and Communities
1 Mar 2016 in Hor
EU funding (€250,000): Bioinformatics Services for Data-Driven Design of Cell Factories and Communities
13 May 2015
Director (1)
12 May 2015
Persons · Capital: 109,333 DKK · Proxy · Company statute
7 May 2015
Member of the Executive Board (1)
7 May 2015
Member of the Executive Board: Søren Knud Carlsen
1 Apr 2015
Annual report for the year ending 31/12/2014
1 Jan 2015 in Fts
EU funding (€282,895): 642738 - MetaRNA - RNA-Based Technologies for Single-Cell Metabolite Analysis
1 Jan 2015 via BioNTech Real Estate Holding GmbH
EU funding (€290,082): RNA-based technologies for single-cell metabolite analysis
28 May 2014
Director: Tiltrådt Som Adm · No longer Director: Morten O. A. Sommer · Member of the Executive Board: C Scient pol Henrik Dalbøge (Formand) · Proxy · Company statute
13 May 2014
CEO: Henrik Dalbøge
12 May 2014
Annual report for the year ending 31/12/2013
5 Dec 2013
Auditor: Datoselskabet af den 3. Juli 2016 RVT P/S, RSM Plus ApS Statsautoriserede Revisorer
1 Dec 2013 in Fts
EU funding (€718,000): Grant FP7 - 613745 - Promys
21 Dec 2012
Reg­is­tra­tion · Director (2) · Auditor: RSM Plus ApS Statsautoriserede Revisorer · Capital: 80M DKK · Proxy

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "Biosyntia ApS, Copenhagen, Denmark" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.
Close